Intermediate for Antineoplastic Drugs 5-Chloro-1-Methyl-4-Nitroimidazole CAS 4897-25-0

Name: Intermediate for Antineoplastic Drugs 5-Chloro-1-Methyl-4-Nitroimidazole CAS 4897-25-0
Brand: Jinan Qinmu Fine Chemical Co., Ltd.
SKU: 1966888775

Shandong, ChinaJinan Qinmu Fine Chemical Co., Ltd.

US$1.00-50.00

1 kg

Sample price:US$50.00/kg.Request sample

Product profile

Customization

Available

CAS No.

4897-25-0

Formula

C4h4cln3o2

Model NO.

852

EINECS

225-521-2

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Refined

Colour

White

Melting Point

148

Boiling Point

362.3

Density

1.9518

Transport Package

25kg/Drum

Specification

99%

Trademark

Qinmu

Origin

China

Company profile

Jinan Qinmu Fine Chemical Co., Ltd.

Shandong, China

Business Type: Trading CompanyExport Year: 2008-04-01Nearest Port: qindao port, shanghai port, guanzhou portAverage Response Time: ≤7.59hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryThe supplier is a specialty and functional chemicals manufacturer associated with Qinmu Chemical Group, with stated pharmaceutical-intermediate synthesis and production of PETMP, 3-Mercaptopropionic acid series, and other functional chemical materials. It reports quality assurance, raw-material traceability, inventory capability, supplier-management procedures, and peak/off-season lead times within 15 workdays. Its customization capability is broad, covering samples, minor or full customization, designs, and flexible customization. However, it is not identified as a professional technical supplier, does not provide 3D software design, had no new products in the past year, and lacks SDK availability. The supplier has no overseas warehouse, showroom, agent, or branch service capability according to the service-capacity data, although another company description states that an Indian branch was established; this inconsistency should be verified. Certification evidence is limited to a company-description...

CertificationsThe company description states that it passed ISO9001 and ISO14001 certification in 2019. The slices do not provide current certificate validity, certificate numbers, or certification scope, so the evidence supports historical certification but not current status.

R&D capabilityThe supplier offers ODM service and has a history of launching functional chemical materials, but it reports no new products in the past year, no SDK, no 3D software design service, and no professional technical-supplier R&D capability. These findings indicate limited evidence of current innovation capability.

Production capacityThe supplier has stated production experience in pharmaceutical intermediates and functional chemical materials, inventory capability, one quality inspector, raw-material traceability, random finished-product inspection, and lead times within 15 workdays in both seasons. The evidence supports an established production operation, although production capacity and scale are not quantified.

Customization capabilityThe supplier explicitly supports flexible customization, customization from samples, minor customization, full customization, and customization from designs. This broad list directly indicates strong flexibility for customized requirements, although 3D software design is unavailable.